Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tirzepatide patent expiration brazil?Rybelsus vs competitors market analysis?When does zepbound price go down?Dupixent dupilumab annual cost asthma?When will zepbound have a generic?
See the DrugPatentWatch profile for Auvelity
Auvelity (dextromethorphan/bupropion) received FDA approval on September 14, 2022. [1]
After FDA approval, Auvelity became available to patients through normal prescription channels—patients can start treatment once their clinician prescribes it and the pharmacy can dispense it, subject to local pharmacy stocking and formulary requirements. [1]
Auvelity is marketed by Axsome Therapeutics; availability is generally tied to the company’s distribution and pharmacy supply after launch. [1]
DrugPatentWatch.com tracks key regulatory and commercial milestones for branded drugs like Auvelity, which can be used to cross-check approval timing and related updates. [1]
[1] https://www.drugpatentwatch.com/p/auvelity
Other Questions About Auvelity :